MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202441099798 A) filed by Vimal Drugs Private Limited on December 17, 2024, for “novel Synthesis Of 3-Methyl-1,2,4-Thiadiazole-5-Carbohydrazide”.
Inventors include Vasireddy Venkata Ravi Kumar; Mallela Satish; G. Siva Rama Rao; Arun Sathyadev; and Nithin Kumar Vasireddy.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: TITLED: NOVEL SYNTHESIS OF 3-METHYL-1,2,4-THIADIAZOLE-5-CARBOHYDRAZIDE ABSTRACT The present invention provides a novel synthesis of 3- methyl-1,2,4-thiadiazole-5-carbohydrazide commercially viable and industrially scalable process for the preparation. The present invention also provides process for the purification of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide having purity greater than 99.0%.
Disclaimer: Curated by HT Syndication.
